-
Published 7/10/2026
Watling CZ, Watts EL, Loftfield E, Graubard BI, Hong HG, Zhang X, Barnett MJ, Buring JE, Barnard ME, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Purdue MP, Sesso HD, Shrubsole M, Sinha R, Tinker L, Triplette M, Um CY, Visvanathan K, Wactawski-Wende J, Willett WC, Wu F, Zheng W, Campbell PT, Barupal D, Petrick JL, Mcglynn KA. Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts. J Natl Cancer Inst. 2026 Jul 10. PMID: 42429571.
-
Published 6/25/2026
Beachler DC, Parlett LE, Petrick JL, Lanes S, Barron J, Debono D, Fisch MJ. Comparative risk factors among pancreatic adenocarcinoma patients vs. neuroendocrine and other pancreatic cancer patients. Cancer Causes Control. 2026 Jun 25; 37(7). PMID: 42347880.
-
Published 6/1/2026
Watling CZ, Zhao L, Zhang X, Deubler E, Gonzalez-Feliciano AG, Graubard BI, Petrick JL, Wojt A, Butera G, Hofmann JN, Beane Freeman LE, Shrubsole MJ, Zheng W, Sudenga SL, Schernhammer E, Eliassen AH, Mucci LA, Sesso HD, Sinha R, Loftfield E, Um CY, McCullough ML, Jenab M, Zhang X, McGlynn KA. Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer. JAMA Netw Open. 2026 Jun 01; 9(6):e2617754. PMID: 42268607.
-
Published 5/5/2026
Petrick JL, Castro-Webb N, Zirpoli GR, Nelson KP, Palmer JR, Pfeiffer RM. Validation of a colorectal cancer risk prediction model in US Black women. Cancer Prev Res (Phila). 2026 May 05. PMID: 42083882.
-
Published 3/22/2026
Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a swedish population-based cohort study. J Natl Cancer Inst. 2026 Mar 22. PMID: 41866298.